Facial Fat Transfer Market Research Report - Global Forecast till 2027

Global Facial Fat Transfer Market: Information by Target Area (Naso-Labial Folds, Lips, Marionette Folds, Temples, Chin, Under-Eye Area), Treatment (Dermal Fillers, Fat Injection, Others), End-User (Hospitals, Cosmetic Surgery Clinics, Others) and Region (North America, Europe, Asia-Pacific & Middle East & Africa) - Forecast till 2027

ID: MRFR/MED/1248-CR | December, 2019 | Region : Global

Market Overview


Facial Fat Transfer Market is expected to register a CAGR of 11.05% to reach USD 7789.1 Million by 2025.


Facial fat transfer is also known as fat grafting, fat injection, or lipofilling. This process is carried out by using the patient’s body fat from hips, thighs, or stomach to add volume to the face. Facial fat transfer is usually performed to restore sunken cheeks and hollow-looking eyes, thin lips, reduce wrinkles, smooth deep nasolabial folds, and reshape the face. The market is growing at a rapid pace due to the increasing demand for facial fat transfer treatment, advanced technology in the facial rejuvenation industry, and rising aging population.


Market Dynamics


Facial aesthetic surgery is one of the latest cosmetic surgical and non-surgical technology used nowadays. Due to rising cases of various skin disorders in developing and developed economies, the global facial fat transfer market is expected to grow at a steady rate during the forecast period as these aesthetic procedures are used to treat skin disorders. Awareness regarding body aesthetics is growing due to various factors. The rising importance of body aesthetics is seen in recent years, mainly due to the high demand for liposuction, hair transplantation, the increasing obese and geriatric population, growing expenditure on cosmetic surgeries, prevalence of skin diseases, technological advancements in the aesthetic industry, and increasing acceptance of facial aesthetics. Hence, the increasing demand for body aesthetics is expected to drive the market growth.


Global Facial Fat Transfer Market Revenue, by Target Area, 2025 (USD Million)  Facial Fat Transfer Market


 Sources: MRFR Analysis


Segmentation


The Global Facial Fat Transfer Market has been segmented on the basis of the Target Area, Treatment, and End User. The market, based on target area, has been segmented into nasolabial folds, marionette folds, lips, under-eye area, temples, and chin. The nasolabial folds segment is expected to lead the market and register a substantial CAGR to reach USD 2213.8 Million by the end of 2025. The global facial fat transfer market based on treatment has been classified as fat injection, dermal fillers, and others. The global facial fat transfer market, by end user, has been categorized as hospitals, cosmetic surgery clinics, and others.


Global Facial Fat Transfer Market Share, by Region, 2018 (%)  Facial Fat Transfer Market


Sources: MRFR Analysis


Regional Analysis


The Americas account for the largest share of the global facial fat transfer market, owing to the growing demand for beauty treatments, and the presence of major players in the region. Non- invasive fat reduction and skin-tightening procedures are gaining popularity among patients. For instance, according to the American Society of plastic surgeons, in 2017, injection-based procedures that target fat pockets in specific areas such as under the skin, increased by 18%. Moreover, there is a rising demand for facial fat transfer in the Americas. Henceforth, the increasing success rate of facial fat grafting procedures is expected to drive the growth of the market in the region.


Europe is considered to be the second-largest global facial fat transfer market owing to the increasing demand for facial fat transfer in this region. In Europe, most countries have the policy of reimbursement which is a major factor driving the growth of the market. Additionally, there is an increasing demand for minimally invasive cosmetic procedures that enhance the young-looking appearance as well as demand for dermal fillers in this region. For instance, according to the British Association of Aesthetic Plastic Surgeons, in London, 2019, over 28,000 cosmetic procedures took place in 2018. Moreover, the aggressive marketing of facial fat transfer products by European companies in other countries is leading to the growth of this region. The increasing awareness of aesthetics is estimated to drive the growth of the market in the region.


The market in Asia-Pacific is expected to register a significant growth rate during the forecast period owing to the increasing success rate of facial fat transfer procedures. An increasing number of hospitals and increasing healthcare infrastructure are likely to support the growth of this region in the facial fat transfer market.


The market in the Middle East & Africa is likely to exhibit the lowest growth owing to the limited access and availability of treatment facilities.


Key Players


The Prominent Players in the Global Facial Fat Transfer Market are Allergan (Ireland), DR. Korman (Israel), Galderma Laboratories, L.P. (US), Integra LifeSciences Corporation (Israel), Merz Pharma (Germany), SciVision Biotech Inc (Taiwan), Sinclair Pharma (UK), Suneva Medical, Inc (US), Bausch Health Companies Inc (Canada), Teoxane Laboratories (Switzerland), and Ipsen Pharma (France).


Market Segmentation


Global Facial Fat Transfer Market, by Target Area



  • Naso-Labial Folds

  • Lips

  • Marionette Folds

  • Temples

  • Chin

  • Under-Eye Area


Global Facial Fat Transfer Market, by Treatment    



  • Dermal Fillers

  • Fat Injection

  • Others


Global Facial Fat Transfer Market, by End User



  • Hospitals

  • Cosmetic Surgery Clinics

  • Others


Global Facial Fat Transfer Market, by Region



  • America

    • North America

      • US

      • Canada



    • Latin America





  • Europe

    • Western Europe

      • Germany

      • UK

      • France

      • Spain

      • Italy

      • Rest of Western Europe



    • Eastern Europe





  • Asia-Pacific

    • China

    • India

    • Japan

    • Australia

    • South Korea

    • Rest of Asia-Pacific





  • Middle East & Africa

    • Middle East

    • Africa




Available Additional Customizations



  • Market Trends

  • Mega Trends


Intended Audience



  • Governments, associations, and industrial bodies

  • Investors and trade experts

  • Medical research laboratories

  • Research and development (R&D) companies

  • Market research and consulting service providers

  • Potential investors

1 EXECUTIVE SUMMARY

1.1 MARKET SYNOPSIS 16

1.2 MARKET ATTRACTIVENESS ANALYSIS 17

1.3 GLOBAL FACIAL FAT TRANSFER MARKET, BY TARGET AREA 18

1.4 GLOBAL FACIAL FAT TRANSFER MARKET, BY TREATMENT 19

1.5 GLOBAL FACIAL FAT TRANSFER MARKET, BY END USER 20

2 MARKET INTRODUCTION

2.1 DEFINITION 21

2.2 SCOPE OF THE STUDY 21

2.3 RESEARCH OBJECTIVE 21

2.4 MARKET STRUCTURE 21

2.5 ASSUMPTIONS & LIMITATIONS 22

3 RESEARCH METHODOLOGY

3.1 DATA MINING 23

3.2 SECONDARY RESEARCH 24

3.3 PRIMARY RESEARCH 25

3.4 BREAKDOWN OF PRIMARY RESPONDENTS 26

3.5 FORECASTING TECHNIQUES 27

3.6 RESEARCH METHODOLOGY FOR MARKET SIZE ESTIMATION 28

3.6.1 BOTTOM-UP APPROACH 29

3.6.2 TOP-DOWN APPROACH 29

3.7 DATA TRIANGULATION 30

3.8 VALIDATION 30

4 MARKET DYNAMICS

4.1 OVERVIEW 31

4.2 DRIVERS 32

4.2.1 RISING IMPORTANCE OF BODY AESTHETICS 32

4.2.2 SOCIAL AND CULTURAL FACTORS SUCH AS INFLUENCE OF FASHION AND FILM INDUSTRIES 32

4.3 RESTRAINTS 33

4.3.1 STRINGENT REGULATORY POLICIES 33

4.3.2 LACK OF AWARENESS FOR THE USE OF ADVANCED TECHNOLOGIES 33

4.4 OPPORTUNITIES 34

4.4.1 ENTERING DEVELOPING ECONOMIES 34

4.4.2 RISING DEMAND FOR MINIMALLY INVASIVE PROCEDURES 34

5 MARKET FACTOR ANALYSIS 35

5.1 PORTER’S FIVE FORCES MODEL 35

5.1.1 BARGAINING POWER OF SUPPLIERS 35

5.1.2 BARGAINING POWER OF BUYERS 36

5.1.3 THREAT OF NEW ENTRANTS 36

5.1.4 THREAT OF SUBSTITUTES 36

5.1.5 INTENSITY OF RIVALRY 36

5.2 VALUE CHAIN ANALYSIS 37

5.2.1 R&D AND DESIGNING 38

5.2.2 MANUFACTURING 38

5.2.3 DISTRIBUTION 38

5.2.4 MARKETING & SALES 38

5.2.5 POST-SALES MONITORING 38

5 MARKET FACTOR ANALYSIS

5.1 PORTER’S FIVE FORCES MODEL 35

5.1.1 BARGAINING POWER OF SUPPLIERS 35

5.1.2 BARGAINING POWER OF BUYERS 36

5.1.3 THREAT OF NEW ENTRANTS 36

5.1.4 THREAT OF SUBSTITUTES 36

5.1.5 INTENSITY OF RIVALRY 36

5.2 VALUE CHAIN ANALYSIS 37

5.2.1 R&D AND DESIGNING 38

5.2.2 MANUFACTURING 38

5.2.3 DISTRIBUTION 38

5.2.4 MARKETING & SALES 38

5.2.5 POST-SALES MONITORING 38

6 FACIAL FAT TRANSFER MARKET, BY TARGET AREA

6.1 OVERVIEW 39

6.2 NASO-LABIAL FOLDS 40

6.3 LIPS 41

6.4 MARIONETTE FOLDS 41

6.5 TEMPLES 42

6.6 CHIN 43

6.7 UNDER-EYE AREA 43

7 GLOBAL FACIAL FAT TRANSFER MARKET, TREATMENT

7.1 OVERVIEW 45

7.2 DERMAL FILLERS 46

7.3 FAT INJECTION 48

8 GLOBAL FACIAL FAT TRANSFER MARKET, END USER

8.1 OVERVIEW 49

8.2 HOSPITALS 50

8.3 COSMETIC SURGERY CLINICS 51

8.4 OTHERS 51

9 GLOBAL FACIAL FAT TRANSFER MARKET, BY REGION

9.1 OVERVIEW 52

9.2 AMERICAS 53

FACIAL FAT TRANSFER MARKET, BY TARGET AREA

9.2.1 NORTH AMERICA 56

FACIAL FAT TRANSFER MARKET, BY TARGET AREA

9.2.1.1 US 59

FACIAL FAT TRANSFER MARKET, BY TARGET AREA

9.2.1.2 CANADA 61

FACIAL FAT TRANSFER MARKET, BY TARGET AREA

9.2.2 LATIN AMERICA 63

FACIAL FAT TRANSFER MARKET, BY TARGET AREA

9.3 EUROPE 65

FACIAL FAT TRANSFER MARKET, BY TARGET AREA

9.3.1 WESTERN EUROPE 68

FACIAL FAT TRANSFER MARKET, BY TARGET AREA

9.3.1.1 ITALY 71

FACIAL FAT TRANSFER MARKET, BY TARGET AREA

9.3.1.2 FRANCE 73

FACIAL FAT TRANSFER MARKET, BY TARGET AREA

9.3.1.3 GERMANY 75

FACIAL FAT TRANSFER MARKET, BY TARGET AREA

9.3.1.4 UK 77

FACIAL FAT TRANSFER MARKET, BY TARGET AREA

9.3.1.5 SPAIN 79

FACIAL FAT TRANSFER MARKET, BY TARGET AREA

9.3.1.6 REST OF WESTERN EUROPE 81

FACIAL FAT TRANSFER MARKET, BY TARGET AREA

9.4 EASTERN EUROPE 83

FACIAL FAT TRANSFER MARKET, BY TARGET AREA

9.5 ASIA-PACIFIC 85

FACIAL FAT TRANSFER MARKET, BY TARGET AREA

9.5.1 JAPAN 88

FACIAL FAT TRANSFER MARKET, BY TARGET AREA

9.5.2 CHINA 90

FACIAL FAT TRANSFER MARKET, BY TARGET AREA

9.5.3 INDIA 92

FACIAL FAT TRANSFER MARKET, BY TARGET AREA

9.5.4 SOUTH KOREA 94

FACIAL FAT TRANSFER MARKET, BY TARGET AREA

9.5.5 AUSTRALIA 96

FACIAL FAT TRANSFER MARKET, BY TARGET AREA

9.5.6 REST OF ASIA-PACIFIC 98

FACIAL FAT TRANSFER MARKET, BY TARGET AREA

9.6 MIDDLE EAST & AFRICA 100

FACIAL FAT TRANSFER MARKET, BY TARGET AREA

9.6.1 MIDDLE EAST 103

FACIAL FAT TRANSFER MARKET, BY TARGET AREA

9.6.2 AFRICA 105

FACIAL FAT TRANSFER MARKET, BY TARGET AREA

10 COMPETITIVE LANDSCAPE

10.1 OVERVIEW 107

10.2 COMPANY SHARE ANALYSIS 107

10.3 COMPETITIVE BENCHMARKING 108

10.4 LEADING PLAYER IN TERMS OF NUMBER OF DEVELOPMENTS IN FACIAL FAT TRANSFER MARKET 109

10.5 KEY DEVELOPMENT ANALYSIS 109

10.5.1 PRODUCT LAUNCH 110

10.5.2 APPROVAL 110

10.5.3 MERGER & ACQUISITION 111

10.5.4 EXPANSION 112

10.5.5 PARTNERSHIPS AND AGREEMENTS 113

11 COMPANY PROFILE

11.1 ALLERGAN 114

11.1.1 COMPANY OVERVIEW 114

11.1.2 FINANCIAL OVERVIEW 115

11.1.3 PRODUCTS/SERVICES OFFERED 115

11.1.4 KEY DEVELOPMENTS 116

11.1.5 SWOT ANALYSIS 117

11.1.6 KEY STRATEGIES 117

11.2 DR. KORMAN 118

11.2.1 COMPANY OVERVIEW 118

11.2.2 FINANCIAL OVERVIEW 118

11.2.3 PRODUCTS/SERVICES OFFERED 118

11.2.4 KEY DEVELOPMENTS 118

11.2.5 SWOT ANALYSIS 119

11.2.6 KEY STRATEGIES 119

11.3 GALDERMA LABORATORIES, L.P. 120

11.3.1 COMPANY OVERVIEW 120

11.3.2 FINANCIAL OVERVIEW 120

11.3.3 PRODUCTS/SERVICES OFFERED 121

11.3.4 KEY DEVELOPMENTS 121

11.3.5 SWOT ANALYSIS 122

11.3.6 KEY STRATEGIES 122

11.4 INTEGRA LIFESCIENCES CORPORATION 123

11.4.1 COMPANY OVERVIEW 123

11.4.2 FINANCIAL OVERVIEW 123

11.4.3 PRODUCTS/SERVICES OFFERED 124

11.4.4 KEY DEVELOPMENTS 124

11.4.5 SWOT ANALYSIS 125

11.4.6 KEY STRATEGIES 125

11.5 MERZ PHARMA 126

11.5.1 COMPANY OVERVIEW 126

11.5.2 FINANCIAL OVERVIEW 126

11.5.3 PRODUCTS/SERVICES OFFERED 127

11.5.4 KEY DEVELOPMENTS 127

11.5.5 SWOT ANALYSIS 128

11.5.6 KEY STRATEGIES 128

11.6 SCIVISION BIOTECH INC. 129

11.6.1 COMPANY OVERVIEW 129

11.6.2 FINANCIAL OVERVIEW 129

11.6.3 PRODUCTS/SERVICES OFFERED 129

11.6.4 KEY DEVELOPMENTS 129

11.6.5 SWOT ANALYSIS 130

11.6.6 KEY STRATEGIES 130

11.7 SINCLAIR PHARMA 131

11.7.1 COMPANY OVERVIEW 131

11.7.2 FINANCIAL OVERVIEW 131

11.7.3 PRODUCTS/SERVICES OFFERED 132

11.7.4 KEY DEVELOPMENTS 132

11.7.5 SWOT ANALYSIS 133

11.7.6 KEY STRATEGIES 133

11.8 SUNEVA MEDICAL 134

11.8.1 COMPANY OVERVIEW 134

11.8.2 FINANCIAL OVERVIEW 134

11.8.3 PRODUCTS/SERVICES OFFERED 134

11.8.4 KEY DEVELOPMENTS 134

11.8.5 SWOT ANALYSIS 135

11.8.6 KEY STRATEGIES 135

11.9 BAUSCH HEALTH COMPANIES INC. 136

11.9.1 COMPANY OVERVIEW 136

11.9.2 FINANCIAL OVERVIEW 136

11.9.3 PRODUCTS/SERVICES OFFERED 137

11.9.4 KEY DEVELOPMENTS 137

11.9.5 SWOT ANALYSIS 138

11.9.6 KEY STRATEGIES 138

11.10 TEOXANE LABORATORIES 139

11.10.1 COMPANY OVERVIEW 139

11.10.2 FINANCIAL OVERVIEW 139

11.10.3 PRODUCTS/SERVICES OFFERED 139

11.10.4 KEY DEVELOPMENTS 139

11.10.5 SWOT ANALYSIS 140

11.10.6 KEY STRATEGIES 140

11.11 IPSEN PHARMA 141

11.11.1 COMPANY OVERVIEW 141

11.11.2 FINANCIAL OVERVIEW 141

11.11.3 PRODUCTS/SERVICES OFFERED 142

11.11.4 KEY DEVELOPMENTS 142

11.11.5 SWOT ANALYSIS 143

11.11.6 KEY STRATEGIES 143

12 APPENDIX

12.1 REFERENCES 144

12.2 RELATED REPORTS 144

13 LIST OF TABLES

TABLE 1 LIST OF ASSUMPTIONS 22

TABLE 2 PRIMARY INTERVIEWS AND INFORMATION GATHERING PROCESS 25

TABLE 3 GLOBAL FACIAL FAT TRANSFER MARKET, BY TARGET AREA, 2020–2027 (USD MILLION) 40

TABLE 4 GLOBAL FACIAL FAT TRANSFER MARKET FOR NASO-LABIAL FOLDS, BY REGION, 2020–2027 (USD MILLION) 40

TABLE 5 GLOBAL FACIAL FAT TRANSFER MARKET FOR LIPS, BY REGION, 2020–2027 (USD MILLION) 41

TABLE 6 GLOBAL FACIAL FAT TRANSFER MARKET FOR MARIONETTE FOLDS, BY REGION, 2020–2027 (USD MILLION) 42

TABLE 7 GLOBAL FACIAL FAT TRANSFER MARKET FOR TEMPLES, BY REGION, 2020–2027 (USD MILLION) 42

TABLE 8 GLOBAL FACIAL FAT TRANSFER MARKET FOR CHIN, BY REGION, 2020–2027 (USD MILLION) 43

TABLE 9 GLOBAL FACIAL FAT TRANSFER MARKET FOR UNDER-EYE AREA, BY REGION, 2020–2027 (USD MILLION) 43

TABLE 10 GLOBAL FACIAL FAT TRANSFER MARKET, BY TREATMENT, 2020–2027 (USD MILLION) 46

TABLE 11 GLOBAL FACIAL FAT TRANSFER MARKET FOR DERMAL FILLERS, BY REGION, 2020–2027 (USD MILLION) 47

TABLE 12 GLOBAL FACIAL FAT TRANSFER MARKET FOR DERMAL FILLERS, BY TYPE, 2020–2027 (USD MILLION) 47

TABLE 13 GLOBAL FACIAL FAT TRANSFER MARKET FOR FAT INJECTION, BY REGION, 2020–2027 (USD MILLION) 48

TABLE 14 GLOBAL FACIAL FAT TRANSFER MARKET, BY END USER, 2020–2027 (USD MILLION) 50

TABLE 15 GLOBAL FACIAL FAT TRANSFER MARKET FOR HOSPITALS, BY REGION, 2020–2027 (USD MILLION) 50

TABLE 16 GLOBAL FACIAL FAT TRANSFER MARKET FOR COSMETIC SURGERY CLINICS, BY REGION, 2020–2027 (USD MILLION) 51

TABLE 17 AMERICAS: FACIAL FAT TRANSFER MARKET, BY REGION, 2020–2027 (USD MILLION) 53

TABLE 18 AMERICAS: FACIAL FAT TRANSFER MARKET, BY TARGET AREA, 2020–2027 (USD MILLION) 54

TABLE 19 AMERICAS: FACIAL FAT TRANSFER MARKET, BY TREATMENT 2020–2027 (USD MILLION) 54

TABLE 20 AMERICAS: FACIAL FAT TRANSFER MARKET FOR DERMAL FILLERS, BY TYPE, 2020–2027 (USD MILLION) 55

TABLE 21 AMERICAS: FACIAL FAT TRANSFER MARKET, BY END USER 2020–2027 (USD MILLION) 55

TABLE 22 NORTH AMERICA: FACIAL FAT TRANSFER MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 56

TABLE 23 NORTH AMERICA: FACIAL FAT TRANSFER MARKET, BY TARGET AREA, 2020–2027 (USD MILLION) 57

TABLE 24 NORTH AMERICA: FACIAL FAT TRANSFER MARKET, BY TREATMENT 2020–2027 (USD MILLION) 57

TABLE 25 NORTH AMERICA: FACIAL FAT TRANSFER MARKET FOR DERMAL FILLERS, BY TYPE, 2020–2027 (USD MILLION) 58

TABLE 26 NORTH AMERICA: FACIAL FAT TRANSFER MARKET, BY END USER 2020–2027 (USD MILLION) 58

TABLE 27 US: FACIAL FAT TRANSFER MARKET, BY TARGET AREA, 2020–2027 (USD MILLION) 59

TABLE 28 US: FACIAL FAT TRANSFER MARKET, BY TREATMENT 2020–2027 (USD MILLION) 59

TABLE 29 US: FACIAL FAT TRANSFER MARKET FOR DERMAL FILLERS, BY TYPE, 2020–2027 (USD MILLION) 60

TABLE 30 US: FACIAL FAT TRANSFER MARKET, BY END USER 2020–2027 (USD MILLION) 60

TABLE 31 CANADA: FACIAL FAT TRANSFER MARKET, BY TARGET AREA, 2020–2027 (USD MILLION) 61

TABLE 32 CANADA: FACIAL FAT TRANSFER MARKET, BY TREATMENT 2020–2027 (USD MILLION) 61

TABLE 33 CANADA: FACIAL FAT TRANSFER MARKET FOR DERMAL FILLERS, BY TYPE, 2020–2027 (USD MILLION) 62

TABLE 34 CANADA: FACIAL FAT TRANSFER MARKET, BY END USER 2020–2027 (USD MILLION) 62

TABLE 35 LATIN AMERICA: FACIAL FAT TRANSFER MARKET, BY TARGET AREA, 2020–2027 (USD MILLION) 63

TABLE 36 LATIN AMERICA: FACIAL FAT TRANSFER MARKET, BY TREATMENT 2020–2027 (USD MILLION) 63

TABLE 37 LATIN AMERICA: FACIAL FAT TRANSFER MARKET FOR DERMAL FILLERS, BY TYPE, 2020–2027 (USD MILLION) 64

TABLE 38 LATIN AMERICA: FACIAL FAT TRANSFER MARKET, BY END USER 2020–2027 (USD MILLION) 64

TABLE 39 EUROPE: FACIAL FAT TRANSFER MARKET, BY REGION, 2020–2027 (USD MILLION) 65

TABLE 40 EUROPE: FACIAL FAT TRANSFER MARKET, BY TARGET AREA, 2020–2027 (USD MILLION) 66

TABLE 41 EUROPE: FACIAL FAT TRANSFER MARKET, BY TREATMENT 2020–2027 (USD MILLION) 66

TABLE 42 EUROPE: FACIAL FAT TRANSFER MARKET FOR DERMAL FILLERS, BY TYPE, 2020–2027 (USD MILLION) 67

TABLE 43 EUROPE: FACIAL FAT TRANSFER MARKET, BY END USER 2020–2027 (USD MILLION) 67

TABLE 44 WESTERN EUROPE: FACIAL FAT TRANSFER MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 68

TABLE 45 WESTERN EUROPE: FACIAL FAT TRANSFER MARKET, BY TARGET AREA, 2020–2027 (USD MILLION) 69

TABLE 46 WESTERN EUROPE: FACIAL FAT TRANSFER MARKET, BY TREATMENT 2020–2027 (USD MILLION) 69

TABLE 47 WESTERN EUROPE: FACIAL FAT TRANSFER MARKET FOR DERMAL FILLERS, BY TYPE, 2020–2027 (USD MILLION) 70

TABLE 48 WESTERN EUROPE: FACIAL FAT TRANSFER MARKET, BY END USER 2020–2027 (USD MILLION) 70

TABLE 49 ITALY: FACIAL FAT TRANSFER MARKET, BY TARGET AREA, 2020–2027 (USD MILLION) 71

TABLE 50 ITALY: FACIAL FAT TRANSFER MARKET, BY TREATMENT 2020–2027 (USD MILLION) 71

TABLE 51 ITALY: FACIAL FAT TRANSFER MARKET FOR DERMAL FILLERS, BY TYPE, 2020–2027 (USD MILLION) 72

TABLE 52 ITALY: FACIAL FAT TRANSFER MARKET, BY END USER 2020–2027 (USD MILLION) 72

TABLE 53 FRANCE: FACIAL FAT TRANSFER MARKET, BY TARGET AREA, 2020–2027 (USD MILLION) 73

TABLE 54 FRANCE: FACIAL FAT TRANSFER MARKET, BY TREATMENT 2020–2027 (USD MILLION) 73

TABLE 55 FRANCE: FACIAL FAT TRANSFER MARKET FOR DERMAL FILLERS, BY TYPE, 2020–2027 (USD MILLION) 74

TABLE 56 FRANCE: FACIAL FAT TRANSFER MARKET, BY END USER 2020–2027 (USD MILLION) 74

TABLE 57 GERMANY: FACIAL FAT TRANSFER MARKET, BY TARGET AREA, 2020–2027 (USD MILLION) 75

TABLE 58 GERMANY: FACIAL FAT TRANSFER MARKET, BY TREATMENT 2020–2027 (USD MILLION) 75

TABLE 59 GERMANY: FACIAL FAT TRANSFER MARKET FOR DERMAL FILLERS, BY TYPE, 2020–2027 (USD MILLION) 76

TABLE 60 GERMANY: FACIAL FAT TRANSFER MARKET, BY END USER 2020–2027 (USD MILLION) 76

TABLE 61 UK: FACIAL FAT TRANSFER MARKET, BY TARGET AREA, 2020–2027 (USD MILLION) 77

TABLE 62 UK: FACIAL FAT TRANSFER MARKET, BY TREATMENT 2020–2027 (USD MILLION) 77

TABLE 63 UK: FACIAL FAT TRANSFER MARKET FOR DERMAL FILLERS, BY TYPE, 2020–2027 (USD MILLION) 78

TABLE 64 UK: FACIAL FAT TRANSFER MARKET, BY END USER 2020–2027 (USD MILLION) 78

TABLE 65 SPAIN: FACIAL FAT TRANSFER MARKET, BY TARGET AREA, 2020–2027 (USD MILLION) 79

TABLE 66 SPAIN: FACIAL FAT TRANSFER MARKET, BY TREATMENT 2020–2027 (USD MILLION) 79

TABLE 67 SPAIN: FACIAL FAT TRANSFER MARKET FOR DERMAL FILLERS, BY TYPE, 2020–2027 (USD MILLION) 80

TABLE 68 SPAIN: FACIAL FAT TRANSFER MARKET, BY END USER 2020–2027 (USD MILLION) 80

TABLE 69 REST OF WESTERN EUROPE: FACIAL FAT TRANSFER MARKET, BY TARGET AREA, 2020–2027 (USD MILLION) 81

TABLE 70 REST OF WESTERN EUROPE: FACIAL FAT TRANSFER MARKET, BY TREATMENT 2020–2027 (USD MILLION) 81

TABLE 71 REST OF WESTERN EUROPE: FACIAL FAT TRANSFER MARKET FOR DERMAL FILLERS, BY TYPE, 2020–2027 (USD MILLION) 82

TABLE 72 REST OF WESTERN EUROPE: FACIAL FAT TRANSFER MARKET, BY END USER 2020–2027 (USD MILLION) 82

TABLE 73 EASTERN EUROPE: FACIAL FAT TRANSFER MARKET, BY TARGET AREA, 2020–2027 (USD MILLION) 83

TABLE 74 EASTERN EUROPE: FACIAL FAT TRANSFER MARKET, BY TREATMENT 2020–2027 (USD MILLION) 83

TABLE 75 EASTERN EUROPE: FACIAL FAT TRANSFER MARKET FOR DERMAL FILLERS, BY TYPE, 2020–2027 (USD MILLION) 84

TABLE 76 EASTERN EUROPE: FACIAL FAT TRANSFER MARKET, BY END USER 2020–2027 (USD MILLION) 84

TABLE 77 ASIA-PACIFIC: FACIAL FAT TRANSFER MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 85

TABLE 78 ASIA-PACIFIC: FACIAL FAT TRANSFER MARKET, BY TARGET AREA, 2020–2027 (USD MILLION) 86

TABLE 79 ASIA-PACIFIC: FACIAL FAT TRANSFER MARKET, BY TREATMENT 2020–2027 (USD MILLION) 86

TABLE 80 ASIA-PACIFIC: FACIAL FAT TRANSFER MARKET FOR DERMAL FILLERS, BY TYPE, 2020–2027 (USD MILLION) 87

TABLE 81 ASIA-PACIFIC: FACIAL FAT TRANSFER MARKET, BY END USER 2020–2027 (USD MILLION) 87

TABLE 82 JAPAN: FACIAL FAT TRANSFER MARKET, BY TARGET AREA, 2020–2027 (USD MILLION) 88

TABLE 83 JAPAN: FACIAL FAT TRANSFER MARKET, BY TREATMENT 2020–2027 (USD MILLION) 88

TABLE 84 JAPAN: FACIAL FAT TRANSFER MARKET FOR DERMAL FILLERS, BY TYPE, 2020–2027 (USD MILLION) 89

TABLE 85 JAPAN: FACIAL FAT TRANSFER MARKET, BY END USER 2020–2027 (USD MILLION) 89

TABLE 86 CHINA: FACIAL FAT TRANSFER MARKET, BY TARGET AREA, 2020–2027 (USD MILLION) 90

TABLE 87 CHINA: FACIAL FAT TRANSFER MARKET, BY TREATMENT 2020–2027 (USD MILLION) 90

TABLE 88 CHINA: FACIAL FAT TRANSFER MARKET FOR DERMAL FILLERS, BY TYPE, 2020–2027 (USD MILLION) 91

TABLE 89 CHINA: FACIAL FAT TRANSFER MARKET, BY END USER 2020–2027 (USD MILLION) 91

TABLE 90 INDIA: FACIAL FAT TRANSFER MARKET, BY TARGET AREA, 2020–2027 (USD MILLION) 92

TABLE 91 INDIA: FACIAL FAT TRANSFER MARKET, BY TREATMENT 2020–2027 (USD MILLION) 92

TABLE 92 INDIA: FACIAL FAT TRANSFER MARKET FOR DERMAL FILLERS, BY TYPE, 2020–2027 (USD MILLION) 93

TABLE 93 INDIA: FACIAL FAT TRANSFER MARKET, BY END USER 2020–2027 (USD MILLION) 93

TABLE 94 SOUTH KOREA: FACIAL FAT TRANSFER MARKET, BY TARGET AREA, 2020–2027 (USD MILLION) 94

TABLE 95 SOUTH KOREA: FACIAL FAT TRANSFER MARKET, BY TREATMENT 2020–2027 (USD MILLION) 94

TABLE 96 SOUTH KOREA: FACIAL FAT TRANSFER MARKET FOR DERMAL FILLERS, BY TYPE, 2020–2027 (USD MILLION) 95

TABLE 97 SOUTH KOREA: FACIAL FAT TRANSFER MARKET, BY END USER 2020–2027 (USD MILLION) 95

TABLE 98 AUSTRALIA: FACIAL FAT TRANSFER MARKET, BY TARGET AREA, 2020–2027 (USD MILLION) 96

TABLE 99 AUSTRALIA: FACIAL FAT TRANSFER MARKET, BY TREATMENT 2020–2027 (USD MILLION) 96

TABLE 100 AUSTRALIA: FACIAL FAT TRANSFER MARKET FOR DERMAL FILLERS, BY TYPE, 2020–2027 (USD MILLION) 97

TABLE 101 AUSTRALIA: FACIAL FAT TRANSFER MARKET, BY END USER 2020–2027 (USD MILLION) 97

TABLE 102 REST OF ASIA-PACIFIC: FACIAL FAT TRANSFER MARKET, BY TARGET AREA, 2020–2027 (USD MILLION) 98

TABLE 103 REST OF ASIA-PACIFIC: FACIAL FAT TRANSFER MARKET, BY TREATMENT 2020–2027 (USD MILLION) 98

TABLE 104 REST OF ASIA-PACIFIC: FACIAL FAT TRANSFER MARKET FOR DERMAL FILLERS, BY TYPE, 2020–2027 (USD MILLION) 99

TABLE 105 REST OF ASIA-PACIFIC: FACIAL FAT TRANSFER MARKET, BY END USER 2020–2027 (USD MILLION) 99

TABLE 106 MIDDLE EAST & AFRICA: FACIAL FAT TRANSFER MARKET, BY REGION, 2020–2027 (USD MILLION) 100

TABLE 107 MIDDLE EAST & AFRICA: FACIAL FAT TRANSFER MARKET, BY TARGET AREA, 2020–2027 (USD MILLION) 101

TABLE 108 MIDDLE EAST & AFRICA: FACIAL FAT TRANSFER MARKET, BY TREATMENT 2020–2027 (USD MILLION) 101

TABLE 109 MIDDLE EAST & AFRICA: FACIAL FAT TRANSFER MARKET FOR DERMAL FILLERS, BY TYPE, 2020–2027 (USD MILLION) 102

TABLE 110 MIDDLE EAST & AFRICA: FACIAL FAT TRANSFER MARKET, BY END USER 2020–2027 (USD MILLION) 102

TABLE 111 MIDDLE EAST: FACIAL FAT TRANSFER MARKET, BY TARGET AREA, 2020–2027 (USD MILLION) 103

TABLE 112 MIDDLE EAST: FACIAL FAT TRANSFER MARKET, BY TREATMENT 2020–2027 (USD MILLION) 103

TABLE 113 MIDDLE EAST: FACIAL FAT TRANSFER MARKET FOR DERMAL FILLERS, BY TYPE, 2020–2027 (USD MILLION) 104

TABLE 114 MIDDLE EAST: FACIAL FAT TRANSFER MARKET, BY END USER 2020–2027 (USD MILLION) 104

TABLE 115 AFRICA: FACIAL FAT TRANSFER MARKET, BY TARGET AREA, 2020–2027 (USD MILLION) 105

TABLE 116 AFRICA: FACIAL FAT TRANSFER MARKET, BY TREATMENT 2020–2027 (USD MILLION) 105

TABLE 117 AFRICA: FACIAL FAT TRANSFER MARKET FOR DERMAL FILLERS, BY TYPE, 2020–2027 (USD MILLION) 106

TABLE 118 AFRICA: FACIAL FAT TRANSFER MARKET, BY END USER 2020–2027 (USD MILLION) 106

TABLE 119 GLOBAL FACIAL FAT TRANSFER MARKET: COMPANY SHARE ANALYSIS, 2020 (%) 107

TABLE 120 TOP PLAYERS IN TERMS OF NUMBER OF DEVELOPMENTS IN THE FACIAL FAT TRANSFER MARKET 109

TABLE 121 PRODUCT LAUNCH 110

TABLE 122 APPROVAL 110

TABLE 123 MERGER & ACQUISITION 111

TABLE 124 EXPANSION 112

TABLE 125 PARTNERSHIPS AND AGREEMENTS 113

TABLE 126 ALLERGAN: PRODUCTS/SERVICES OFFERED 115

TABLE 127 ALLERGAN: KEY DEVELOPMENTS 116

TABLE 128 DR. KORMAN: PRODUCTS/SERVICES OFFERED 118

TABLE 129 GALDERMA: PRODUCTS/SERVICES OFFERED 121

TABLE 130 GALDERMA: KEY DEVELOPMENTS 121

TABLE 131 INTEGRA: PRODUCTS/SERVICES OFFERED 124

TABLE 132 INTEGRA: KEY DEVELOPMENTS 124

TABLE 133 MERZ PHARMA: PRODUCTS/SERVICES OFFERED 127

TABLE 134 MERZ PHARMA: KEY DEVELOPMENTS 127

TABLE 135 SCIVISION BIOTECH INC.: PRODUCTS/SERVICES OFFERED 129

TABLE 136 SINCLAIR PHARMA: PRODUCTS/SERVICES OFFERED 132

TABLE 137 SINCLAIR PHARMA: KEY DEVELOPMENTS 132

TABLE 138 SUNEVA MEDICAL: PRODUCTS/SERVICES OFFERED 134

TABLE 139 SUNEVA MEDICAL: KEY DEVELOPMENTS 134

TABLE 140 BAUSCH: PRODUCTS/SERVICES OFFERED 137

TABLE 141 TEOXANE: PRODUCTS/SERVICES OFFERED 139

TABLE 142 IPSEN PHARMA: PRODUCTS/SERVICES OFFERED 142

TABLE 143 IPSEN PHARMA: KEY DEVELOPMENTS 142

14 LIST OF FIGURES

FIGURE 1 MARKET SYNOPSIS 16

FIGURE 2 MARKET ATTRACTIVENESS ANALYSIS (2020) 17

FIGURE 3 GLOBAL FACIAL FAT TRANSFER MARKET ANALYSIS, BY TARGET AREA 18

FIGURE 4 GLOBAL FACIAL FAT TRANSFER MARKET ANALYSIS, BY TREATMENT 19

FIGURE 5 GLOBAL FACIAL FAT TRANSFER MARKET ANALYSIS, BY END USER 20

FIGURE 6 GLOBAL FACIAL FAT TRANSFER MARKET: STRUCTURE 21

FIGURE 7 BOTTOM-UP AND TOP-DOWN APPROACHES 28

FIGURE 8 MARKET DYNAMICS: ANALYSIS OF THE GLOBAL FACIAL FAT TRANSFER MARKET 31

FIGURE 9 DRIVER IMPACT ANALYSIS 32

FIGURE 10 RESTRAINT IMPACT ANALYSIS 33

FIGURE 11 PORTER’S FIVE FORCES ANALYSIS: GLOBAL FACIAL FAT TRANSFER MARKET 35

FIGURE 12 VALUE CHAIN ANALYSIS OF THE GLOBAL FACIAL FAT TRANSFER MARKET 37

FIGURE 13 GLOBAL FACIAL FAT TRANSFER MARKET SHARE, BY TARGET AREA, 2020 (%) 39

FIGURE 14 GLOBAL FACIAL FAT TRANSFER MARKET, BY TARGET AREA, 2020 AND 2027 (USD MILLION) 39

FIGURE 15 GLOBAL FACIAL FAT TRANSFER MARKET SHARE, BY TREATMENT, 2020 (%) 45

FIGURE 16 GLOBAL FACIAL FAT TRANSFER MARKET, BY TREATMENT, 2020 AND 2027 (USD MILLION) 45

FIGURE 17 GLOBAL FACIAL FAT TRANSFER MARKET SHARE, BY END USER, 2020 (%) 49

FIGURE 18 GLOBAL FACIAL FAT TRANSFER MARKET, BY END USER, 2020 AND 2027 (USD MILLION) 49

FIGURE 19 GLOBAL: FACIAL FAT TRANSFER MARKET, BY REGION 2020 & 2027 (USD MILLION) 52

FIGURE 20 GLOBAL: FACIAL FAT TRANSFER MARKET SHARE, BY REGION 2020 (%) 52

FIGURE 21 AMERICAS: FACIAL FAT TRANSFER MARKET SHARE, BY REGION 2020 (%) 53

FIGURE 22 NORTH AMERICA: FACIAL FAT TRANSFER MARKET SHARE, BY COUNTRY 2020 (%) 56

FIGURE 23 EUROPE: PERFUSION RADIOLOGY MARKET SHARE, BY REGION 2020 (%) 65

FIGURE 24 WESTERN EUROPE: FACIAL FAT TRANSFER MARKET SHARE, BY COUNTRY 2020 (%) 68

FIGURE 25 ASIA-PACIFIC: FACIAL FAT TRANSFER MARKET SHARE, BY COUNTRY2020 (%) 85

FIGURE 26 MIDDLE EAST & AFRICA: PERFUSION RADIOLOGY MARKET SHARE, BY REGION, 2020 (%) 100

FIGURE 27 BENCHMARKING OF MAJOR COMPETITORS 108

FIGURE 28 GLOBAL FACIAL FAT TRANSFER MARKET, COMPETITIVE LANDSCAPE 109

FIGURE 29 ALLERGAN: FINANCIAL OVERVIEW SNAPSHOT 115

FIGURE 30 ALLERGAN: SWOT ANALYSIS 117

FIGURE 31 DR. KORMAN: SWOT ANALYSIS 119

FIGURE 32 GALDERMA: FINANCIAL OVERVIEW SNAPSHOT 120

FIGURE 33 GALDERMA: SWOT ANALYSIS 122

FIGURE 34 INTEGRA: FINANCIAL OVERVIEW SNAPSHOT 123

FIGURE 35 INTEGRA: SWOT ANALYSIS 125

FIGURE 36 MERZ PHARMA: FINANCIAL OVERVIEW SNAPSHOT 126

FIGURE 37 MERZ PHARMA: SWOT ANALYSIS 128

FIGURE 38 SCIVISION BIOTECH INC.: SWOT ANALYSIS 130

FIGURE 39 SINCLAIR PHARMA: FINANCIAL OVERVIEW SNAPSHOT 131

FIGURE 40 SINCLAIR PHARMA: SWOT ANALYSIS 133

FIGURE 41 SUNEVA MEDICAL: SWOT ANALYSIS 135

FIGURE 42 BAUSCH: FINANCIAL OVERVIEW SNAPSHOT 136

FIGURE 43 BAUSCH: SWOT ANALYSIS 138

FIGURE 44 TEOXANE: SWOT ANALYSIS 140

FIGURE 45 IPSEN PHARMA: FINANCIAL OVERVIEW SNAPSHOT 141

FIGURE 46 IPSEN PHARMA: SWOT ANALYSIS 143

Facial Fat Transfer Market